The Science of Cellular Rejuvenation

Understanding how we reverse biological aging at the cellular level

For decades, scientists have searched for ways to slow or reverse aging. At Celljevity, we've developed Prometheus technology—a breakthrough approach that rejuvenates your own cells without altering your DNA.

From Lab Bench to Your Body

The Prometheus Process Simplified

20 Billion Rejuvenated Cells from a Biopsy Smaller Than a Dime

0115 minutes

The Harvest

A 6mm × 6mm skin sample is collected from behind your ear—an area rich in dermal fibroblasts that respond exceptionally well to reprogramming. This tissue maintains high proliferative capacity even in older adults.

0222 days

The Transformation

Your cells enter our GMP-certified laboratory where proprietary small-molecule compounds trigger controlled epigenetic reprogramming. Unlike Yamanaka factors, our protocol stops at the 'newborn cell' stage.

  • Single-cell RNA sequencing
  • Karyotype stability confirmed
  • 95%+ viability check
03Nobel Science

Cellular Memory

Dr. Sun's innovation: safely reprogramming cells by stopping short of full pluripotency. This maintains mesenchymal stem cell-like properties without losing differentiation control or risking tumor formation.

04Treatment Day

Strategic Delivery

Cells migrate to inflammation sites via receptor-mediated homing. Prometheus Cells inherently 'sense' injury signals—damaged tissue releases cytokines that act like cellular GPS coordinates.

Safety Profile vs. Alternatives

TherapyCell SourceGenetic ModificationRejection RiskSafety Record
PrometheusYour own fibroblastsNone (epigenetic only)0%
1,000 patients, 0 serious events
Allogeneic MSCsDonor cellsNone10-20%
Variable donor quality
CAR-T TherapyModified T-cellsCRISPR editingLow but complex
FDA black box warning
iPSC DerivativesReprogrammed cellsYamanaka factorsVariable
Teratoma risk remains
Understanding Aging

Why Do We Age?

Every cell in your body contains biological clocks called telomeres—protective caps on your chromosomes that shorten with age. As telomeres shrink, cells lose their ability to function properly, leading to the signs and symptoms we associate with aging.

Additionally, your cells accumulate 'epigenetic marks'—chemical tags that tell genes when to turn on or off. Over time, these marks accumulate errors, like typos in an instruction manual, causing cells to forget how to function youthfully.

Key Mechanisms of Aging:

  • Telomeres shorten by ~1-2% per year naturally
  • Epigenetic changes affect how genes are expressed
  • Cellular damage accumulates over decades
  • Traditional medicine treats symptoms, not causes

The Journey to Renewal

Your Rejuvenation Process

From collection to results in six precise steps, each designed to ensure the highest quality and safety standards for your cellular therapy.

Tissue Collection
1

Tissue Collection

A small 1cm² skin biopsy is collected from behind the ear under local anesthesia

Cell Isolation
2

Cell Isolation

Fibroblasts are isolated and expanded in our GMP-certified laboratories

Rejuvenation Protocol
3

Rejuvenation Protocol

Proprietary 15-day treatment reverses cellular aging markers to new-born stage

Quality Validation
4

Quality Validation

Single-cell RNA sequencing confirms successful rejuvenation before release

Therapeutic Delivery
5

Therapeutic Delivery

20 billion rejuvenated cells delivered via targeted injection or IV infusion

Results & Monitoring
6

Results & Monitoring

Extended telomeres and rejuvenated cellular markers confirmed through comprehensive testing

Our complete rejuvenation process takes approximately 12 weeks from initial consultation to cell delivery

Learn More

Clinical Observations

Real Results from Real Patients

While our technology is still investigational and individual results vary, our clinical observations from over 1,000 patients show promising patterns:

0%

Telomere Extension

Average increase in telomere length

0%

Cognitive Function

Alzheimer's patients maintained or improved

0%

Autoimmune Relief

Reported significant symptom improvement

0%

Joint Health

Osteoarthritis patients showed improvement

Important Note: These are preliminary observational results. Formal clinical trials are ongoing to validate these findings. Results vary by individual.

Comparative Evidence

Why Epigenetic Reprogramming Outperforms

The longevity industry is crowded with promises. Here's how Prometheus Therapy compares using published scientific evidence, not marketing claims.

TechnologyCompany ExampleApproachKey RiskClinical Stage
Epigenetic Reprogramming
CelljevitySmall-molecule reset to 'newborn' state
Minimal (1,000 patients, 0 serious AEs)
1,000+ patients treated
Partial Yamanaka
Altos Labs, Retro BioIn vivo gene therapy (OSKM)
Teratoma risk if overdone
Preclinical (animal studies)
CRISPR Base Editing
Verve TherapeuticsPermanent DNA changes
Off-target edits; irreversible
Phase I trials
Senolytics Only
Unity BiotechnologyClear senescent cells
Doesn't regenerate tissue
Phase II
Allogeneic MSCs
MesoblastDonor stem cells
10-20% rejection; GVHD risk
Phase III

Epigenetic vs. Genetic Editing

The Stanford Insight

"Unlike gene editing, epigenome editing is reversible, safer, and promising for complex diseases." — Dr. Mark Mercola

CRISPR

Permanent DNA Rewrite

Irreversible

Epigenetics

Gene Expression Reset

Fully Reversible

The Cancer Question

Standard Yamanaka reprogramming (OSKM) creates pluripotent stem cells that can form teratomas (tumors). Celljevity's innovation stops at the mesenchymal stem cell-like stage—retaining regenerative capacity without tumor risk.

Safety Record

7 Years

Patients

1,000+

Teratomas

Zero

Safety First

Your Safety is Our Priority

With over 1,000 patients treated since 2018, we maintain the highest safety standards because we're not just treating patients—we're pioneering a new field of medicine.

Zero Adverse Events
ZERO serious treatment-related adverse events across all 1,000+ patients treated since 2018.
GMP Certified Facilities
GMP-certified facilities meeting pharmaceutical standards with the highest manufacturing quality protocols.
RNA Sequencing Quality Control
Every batch tested with single-cell RNA sequencing using advanced quality control methods.
FDA Regulatory Pathway
FDA regulatory pathway established providing a clear path to regulatory approval and broader access.
24/7 Patient Monitoring
Continuous monitoring and follow-up care with round-the-clock patient support systems.

Explore Our Research

Dive deeper into our 100+ peer-reviewed publications, key research findings, and scientific breakthroughs in our blog.

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.